Woodline Partners’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.06M | Hold |
100,149
| – | – | 0.02% | 603 |
|
|
2025
Q1 | $5.14M | Sell |
100,149
-8,837
| -8% | -$454K | 0.03% | 501 |
|
|
2024
Q4 | $6.03M | Buy |
108,986
+37,417
| +52% | +$2.07M | 0.04% | 446 |
|
|
2024
Q3 | $2.35M | Buy |
+71,569
| New | +$2.35M | 0.02% | 460 |
|
|
2021
Q2 | – | Sell |
-12,310
| Closed | -$397K | – | 629 |
|
|
2021
Q1 | $397K | Buy |
+12,310
| New | +$397K | 0.01% | 400 |
|